📋 Tender Overview
Reference: 20240862
Release date: 25 June 2025
Promoter – Financial Intermediary
TRICARES SAS
Location
Germany
Description
The project will support the promoter's research, development and innovation (RDI) activities, including product development and clinical trials.
Objectives
The aim is to develop an innovative transcatheter tricuspid valve to treat tricuspid regurgitation.
Sector(s)
Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 20 million
Total cost (Approximate amount)
EUR 54 million
Environmental aspects
The specific RDI activities included in the project are expected to be performed in existing facilities without changing their already authorised scope. Therefore, the project activities would not require an Environmental Impact Assessment (EIA) under the Directive 2014/52/EU (amending the Directive 2011/52/EU). Full environmental details will be verified during appraisal.
Procurement
The promoter is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is generally not covered by EU directives on procurement. However, the EIB will require that all project contracts are procured in accordance with the applicable EU procurement legislation. The Bank's services will verify details during the project due diligence.
Status
Under appraisal
